This class is closed, please navigate here to look for open classes
DATES AND TIMES:
DAY ONE-Thursday, August 30, 2018
7:00 a.m.-3:30 p.m.
Diamond Head Tower (DHT) Conference Room 1
DAY TWO--Tuesday, September 4, 2018
7:00 a.m.-3:00 p.m.
Conference Room C (Cafeteria) &
DHT Computer Training Room (exam)
Participants must be licensed registered nurses. This course content is appropriate for nurses who are new to pediatric and adolescent chemotherapy and biotherapy administration, as well as for those who want a comprehensive review.
The Association of Pediatric Hematology/Oncology Nurses (APHON) Pediatric Chemotherapy and Biotherapy Provider Course provides a comprehensive review of the knowledge needed to administer cytotoxic and biotherapeutic agents.
Upon successful completion of the course, post-test and evaluation, participants will receive an APHON Pediatric Chemotherapy and Biotherapy Provider Card. This card validates that the participant has completed the education and demonstrated the knowledge needed to administer chemotherapy and biotherapy agents to pediatric patients.
It is the responsibility of the participant to ensure their provider status is renewed with APHON every 3 years on or before the provider card expiration. Information regarding the online renewal process is found on the APHON website at www.aphon.org.
This program may be recognized for the amount of 2.5 hours of pharmacology content indicated as calculated by the APHON Pediatric Chemotherapy/Biotherapy Provider Program Committee. APHON recommends that attendees retain a copy of the provider course brochure for supportive documentation. Please note that you may not apply CNE toward pharmacology content. The content may be applied in only one area, nursing contact hours or pharmacology content.
Upon completion of the course, the participant will be able to:
1. Establish education and practice standards for the administration of chemotherapy and biotherapy to children and adolescents.
2. Promote consistent practices in the administration of chemotherapy and biotherapy to pediatric and adolescent patients.
3. Describe the characteristics of the cancer cell.
4. Identify differences between cancers in adults and cancers in children.
5. List cancer treatment modalities and how response is measured.
6. Discuss the history of chemotherapy.
7. Describe the development of the specialty in childhood cancer treatment.
8. Identify principles for cancer research and informed consent and the role of the nurse.
9. Describe important principles of pharmacokinetics in chemotherapy administration.
10. Discuss classes of chemotherapeutic agents.
11. Define combination chemotherapy.
12. List modes of chemotherapy delivery.
13. Identify biotherapeutic agents.
14. Describe indications and actions of commonly used medications.
15. Identify side effects and nursing interventions for specific biotherapy agents.
16. Recognize classifications for chemotherapeutic agents.
17. Identify common side effects for individual medications.
18. Describe nursing interventions for chemotherapy medications.
19. Describe the occupational exposure risks of chemotherapy/biotherapy.
20. List components of safe handling and disposal practices.
21. Identify components of personal protection equipment.
22. Identify components of pretreatment assessment.
23. List steps in preparation of chemotherapy.
24. Identify nursing measures for different routes of administration.
25. Describe special considerations for vesicant chemotherapy.
26. Identify the type and management of allergic, anaphylactic, and hypersensitivity reactions.
27. Describe required family teaching prior to chemotherapy administration.
28. Identify common side effects of chemotherapy by organ systems.
29. Describe nursing assessment and interventions for common toxicities.
30. List expected medical interventions for each toxicity.
31. Define late effects.
32. Describe examples of late effects by body system.
33. Define quality of life for patients receiving chemotherapy.
34. Describe risk factors for adherence to therapy.
35. Identify unique concerns for adolescents and young adults.
36. Discuss how culture influences patient and family response to chemotherapy.
37. Describe the ethical principles associated with clinical trials.
38. Identify the nurse’s role in informed consent.
39. Discuss legal issues related to chemotherapy administration.
1. Introduction and Standards
2. General Cancer Overview
3. Chemotherapy Overview
4. Principles of Chemotherapy
5. Principles of Biotherapy
6. Chemotherapy: Agents and Classifications
7. Safe Handling of Chemotherapy and Biotherapy Agents
8. Administration Considerations
9. Toxicity and Symptom Management
10. Late Effects of Chemotherapy
11. Psycholosocial Issues
12. Ethical and Legal Considerations
13. Case Studies
The Association of Pediatric Hematology/Oncology Nurses (APHON) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Participants will be awarded 13.75 contact hours upon completion of the course, post-test and evaluation. We urge you to be aware of the continuing education requirements of your own state board of nursing, especially for those states in which CE is mandatory.
Active Chemotherapy/Biotherapy Providers are welcome to sit for the 2 day provider course as a refresher, however they will not be able to take the post exam or earn CNEs. Active providers that wish to renew their provider status must wait until their renewal season is active.
The $350 course fee includes two (2) full days of instruction, all course materials, copy of The Pediatric Chemotherapy and Biotherapy Curriculum, and continuing education credits.
Cancellation must be received at least 1 week prior to the class date. A full refund will be provided if cancellation is received no later than July 18, 2018. A partial refund of $250 is provided for cancellations after July 18, 2018.
ADDITIONAL ACTIVITY INFORMATION:
The APHON Pediatric Chemotherapy and Biotherapy Course is NOT a certification course, and is not intended to measure competency. Individual institutions are responsible for determining their own requirements for assessing clinical competency. All disclosures will be mentioned at the beginning of the course.
Lori Kaneshige MSN, RN
Phone: (808) 983-6409
Things to bring: APHON Member # (if a member; call APHON Member Services at (847) 375-4724 to confirm your number).